Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence.
about
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble saltsAluminum hydroxide injections lead to motor deficits and motor neuron degenerationSafety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studiesA pilot clinical trial of a recombinant ricin vaccine in normal humans.Evidence-based clinical guidelines for immigrants and refugees.Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccine.Is there a need for a new generation of vaccines against pertussis?Anaphylaxis following quadrivalent human papillomavirus vaccination.DPT vaccine-induced lipoatrophy: an observational study.Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine.Staphylococcal enterotoxin B-derived haptens promote sensitizationBiomimetic nanoparticles: preparation, characterization and biomedical applications.Adjuvanted influenza vaccines.Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods.Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination.Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less.Mechanism of immunopotentiation and safety of aluminum adjuvants.Therapeutic effects of PADRE-BAFF autovaccine on rat adjuvant arthritis.Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines-prognosis and outcome after booster vaccination.Fatty acid composition of serum lipid classes in mice following allergic sensitisation with or without dietary docosahexaenoic acid-enriched fish oil substitution.Aluminium adjuvants used in vaccines versus placebo or no intervention
P2860
Q28387541-4F34742F-2D68-4AF1-99BA-17A910197D71Q33644364-CDB4D8AA-FDA2-4F8C-92CB-E68E40C85985Q33891821-8D1115D3-69CB-490D-8415-9EB589BBCD8DQ34479216-95AEDB3C-675F-47CC-9D67-AB3CAF2C495DQ35201293-52117726-3B50-48B9-B8BE-B69310BB021DQ36362292-4FF1B90E-75E4-4678-878B-15DC19682D56Q36458388-720E05D3-C087-449F-BD28-38DA6B9CAEBCQ36856763-19A882FB-E883-43BA-9998-11BAC78EEE71Q36958007-A6C6E99E-C054-4823-99C2-B095BF67D656Q36968308-C24B7694-2B5F-45E2-B44A-ED3E80ACC949Q37729593-C943C704-D69A-49E2-96A2-7481476306C2Q37750489-15C479A4-3434-4FCA-B4B5-E662AFE837D6Q37976540-C6B4582A-9A0E-4477-90A2-B44F72B16767Q38003480-6674B5FF-52CB-4216-9F12-D5E4AE62D7BAQ38209740-96F30B62-F616-4A80-B8CB-8ACBEF1FD9FFQ39708894-F0FE5BD4-5B6D-4AD8-9936-941A633910B6Q39948347-1B97396B-CD97-4222-960E-686FFF28B80AQ42036323-B9D9DD02-8467-4DEC-AF7D-5042272FAF5BQ42107547-E6C3A85D-55A0-47EA-8833-3194E2D7286CQ45990647-4956F1CB-D844-4CEA-9664-6456ADA31E1BQ46898490-8D7483E0-49FE-4BC0-A5F7-C25D372D5E49Q57389398-6E601F48-E975-496C-B933-706F7D55D9FE
P2860
Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Adverse events after immunisat ...... ematic review of the evidence.
@ast
Adverse events after immunisat ...... ematic review of the evidence.
@en
type
label
Adverse events after immunisat ...... ematic review of the evidence.
@ast
Adverse events after immunisat ...... ematic review of the evidence.
@en
prefLabel
Adverse events after immunisat ...... ematic review of the evidence.
@ast
Adverse events after immunisat ...... ematic review of the evidence.
@en
P1476
Adverse events after immunisat ...... ematic review of the evidence.
@en
P2093
Melanie Rudin
Tom Jefferson
P356
10.1016/S1473-3099(04)00927-2
P577
2004-02-01T00:00:00Z